(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
1.95% $ 29.83
Live Chart Being Loaded With Signals
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally...
Stats | |
---|---|
Volumen de hoy | 4.82M |
Volumen promedio | 2.81M |
Capitalización de mercado | 194.12B |
EPS | $0.460 ( 2007-02-07 ) |
Próxima fecha de ganancias | ( $0 ) 2024-06-18 |
Last Dividend | $1.287 ( 2023-03-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 15.30 |
ATR14 | $0.00900 (0.03%) |
Volumen Correlación
Roche Holding AG Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Roche Holding AG Correlación - Moneda/Commodity
Roche Holding AG Finanzas
Annual | 2023 |
Ingresos: | $60.44B |
Beneficio Bruto: | $44.08B (72.94 %) |
EPS: | $14.39 |
FY | 2023 |
Ingresos: | $60.44B |
Beneficio Bruto: | $44.08B (72.94 %) |
EPS: | $14.39 |
FY | 2022 |
Ingresos: | $63.28B |
Beneficio Bruto: | $42.88B (67.77 %) |
EPS: | $15.53 |
Financial Reports:
No articles found.
Roche Holding AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.287 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.211 | 2005-02-28 |
Last Dividend | $1.287 | 2023-03-16 |
Next Dividend | $0 | N/A |
Payout Date | 2023-03-27 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | $16.76 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.88 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.61 | |
Div. Directional Score | 7.32 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PNGAY | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
DWAHF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
UOVEY | Ex Dividend Knight | 2023-08-04 | Annually | 0 | 0.00% | |
KAJMF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
BORT | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
SAFRY | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
FETM | Ex Dividend Knight | 2023-08-04 | Quarterly | 0 | 0.00% | |
YAMHF | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
MCBI | Ex Dividend Junior | 2023-08-04 | Quarterly | 0 | 0.00% | |
CKHGY | Ex Dividend Knight | 2023-05-11 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.12 | 9.18 | [0 - 0.5] |
returnOnAssetsTTM | 0.191 | 1.200 | 3.65 | 4.37 | [0 - 0.3] |
returnOnEquityTTM | 0.618 | 1.500 | 4.25 | 6.37 | [0.1 - 1] |
payoutRatioTTM | 0.442 | -1.000 | 5.58 | -5.58 | [0 - 1] |
currentRatioTTM | 1.347 | 0.800 | 8.26 | 6.61 | [1 - 3] |
quickRatioTTM | 1.026 | 0.800 | 8.67 | 6.94 | [0.8 - 2.5] |
cashRatioTTM | 0.217 | 1.500 | 9.91 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.340 | -1.500 | 4.33 | -6.49 | [0 - 0.6] |
interestCoverageTTM | 30.48 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 29.53 | 2.00 | 0.158 | 0.315 | [0 - 30] |
freeCashFlowPerShareTTM | 21.35 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.050 | -1.500 | 5.80 | -8.70 | [0 - 2.5] |
grossProfitMarginTTM | 0.734 | 1.000 | 1.092 | 1.092 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.284 | 1.000 | 6.32 | 6.32 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.765 | 1.000 | 6.86 | 6.86 | [0.2 - 2] |
assetTurnoverTTM | 0.983 | 0.800 | 6.78 | 5.42 | [0.5 - 2] |
Total Score | 10.03 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 1.247 | 1.000 | 9.98 | 0 | [1 - 100] |
returnOnEquityTTM | 0.618 | 2.50 | 6.30 | 6.37 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 21.35 | 2.00 | 2.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.81 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 29.53 | 2.00 | 0.158 | 0.315 | [0 - 30] |
payoutRatioTTM | 0.442 | 1.500 | 5.58 | -5.58 | [0 - 1] |
pegRatioTTM | 0.0737 | 1.500 | -2.84 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.265 | 1.000 | 5.88 | 0 | [0.1 - 0.5] |
Total Score | 4.61 |
Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico